BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4640793)

  • 1. [Treatment of the edemato-ascitic syndrome in cirrhotics, role of amiloride (MK870)].
    Quinton A; Bancons J; Dubarry JJ
    Bord Med; 1972 Oct; 5(16):2141-9. PubMed ID: 4640793
    [No Abstract]   [Full Text] [Related]  

  • 2. [Furosemide-amiloride combination in the treatment of ascitic-edema in patients with hepatic cirrhosis].
    Uribe M; Rojas S; Casián C; Sierra JG; Moreno J; Lewis H; Guevara L
    Rev Gastroenterol Mex; 1980; 45(2):63-8. PubMed ID: 7403764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of amiloride (MK 870) on water and electrolyte metabolism in ascitic cirrhotics].
    Vesin P; Roberti A; Viguie R
    Schweiz Med Wochenschr; 1969 Jan; 99(1):21-6. PubMed ID: 5790153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of the use of diuretics in the ascitic phase of hepatic cirrhosis].
    Castagnolo B; De Colibus V; Napolitano L; Aliperta A; Caldarelli G; Abignente F
    Clin Ter; 1977 Dec; 83(6):625-9. PubMed ID: 343976
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of the edemato-ascitic syndrome with an injectable aldosterone antagonist: 8109 CB].
    Dubarry JJ; Bancons J; Quinton A
    Bord Med; 1971 Dec; 4(12):3751-7. PubMed ID: 5146181
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of a potassium-sparing diuretic in cardiac edema and ascitic cirrhosis].
    Schena FP; Vox E; Salvatore C
    Clin Ter; 1977 Sep; 82(5):489-94. PubMed ID: 336259
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of diuretic-induced electrolyte disturbances by amiloride in patients with ascites due to cirrhosis of the liver.
    Bianchi Porro G; Petrillo M
    Acta Cardiol; 1973; ():Suppl 17:307-1. PubMed ID: 4543703
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of diuretics from the functional viewpoint. 7. Treatment of edema. (2). Treatment of edema and ascites caused by heart failure or liver cirrhosis].
    Furukawa T
    Saishin Igaku; 1965 Jul; 20(7):1743-58. PubMed ID: 5884753
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Ascrtogenicliver cirrhosis. Effect of amiloride on water-electrolytemetabolsim].
    Bianchi Porre G; Lazzaroni M; Petrillo M
    Nouv Presse Med; 1975 Apr; 4(14):1043. PubMed ID: 1093119
    [No Abstract]   [Full Text] [Related]  

  • 10. The physiopathologic basis and limitations of treatment of cirrhotic edema with diuretics retaining potassium.
    Vesin P
    Mater Med Pol; 1974; 6(3):199-201. PubMed ID: 4444335
    [No Abstract]   [Full Text] [Related]  

  • 11. [Considerations on the treatment of edemato-ascitic syndromes of hepatic origin. Apropos of the utilization of an antialdosterone].
    Levrat R; Savoye B; Imbert D
    J Med Lyon; 1968 Dec; 49(154):1887-99. PubMed ID: 5712102
    [No Abstract]   [Full Text] [Related]  

  • 12. [Furosemide in treatment of the edema syndrome in cirrhotics].
    Nuti M
    Clin Ter; 1965 Sep; 34(6):507-14. PubMed ID: 5852544
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P
    Schweiz Med Wochenschr; 1971 Mar; 101(11):398-401. PubMed ID: 5558553
    [No Abstract]   [Full Text] [Related]  

  • 14. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S; Reynolds TB
    Gastroenterology; 1970 Dec; 59(6):833-41. PubMed ID: 5486268
    [No Abstract]   [Full Text] [Related]  

  • 15. [Water and sodium metabolism in non-compensated hepatic cirrhosis: therapeutic indications according to the Arroyo classification].
    Cavatorta F; Queirolo C; Brignole M; Zangani F
    Clin Ter; 1980 Jan; 92(2):143-53. PubMed ID: 7389274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H; Perret M; Etaix JP
    J Med Lyon; 1967 Feb; 48(114):173-83. PubMed ID: 5600100
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of cardiac edema with a new diuretic (combination of amiloride hydrochlorate and hydrochlorothiazide)].
    Warembourg H; Bertrand ME; Ginestet A
    Lille Med; 1974 Feb; 19(2):193-98. PubMed ID: 4603928
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of amiloride hydrochloride (MK-870) in patients with cirrhosis.
    Grayer D; Iber F
    Johns Hopkins Med J; 1969 Aug; 125(2):78-83. PubMed ID: 5347782
    [No Abstract]   [Full Text] [Related]  

  • 19. [Refractory hepatic cirrosis and the ineffectiveness of diuretics in ascites and edema].
    Inoue J; Mori Y; Kawamura T
    Naika; 1969 Nov; 24(5):834-9. PubMed ID: 4902224
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the new diuretic: Amiloride (MK-870)].
    Jenny M
    Praxis; 1969 Sep; 58(38):1192-6. PubMed ID: 5395178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.